Lung oncology Clinical Trials in Birmingham, AL
As of August 2026, 20 paid clinical trials are recruiting for Lung oncology in Birmingham, Alabama. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
20 clinical trials for Lung oncology
·Clear filters·A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
GEMINI-NSCLC: NSCLC Biomarker Study
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
DISCERN: Dual Versus Single ICB in PDL-1 Negative NSCLC
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
DESTINY-PANTUMOUR04
Top Research Study Locations in Birmingham
Researchers run research studies in Birmingham, AL at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Alabama at Birmingham | Hypertension, Cancer, Cardiovascular Diseases | 345 |
| Children's Hospital of Alabama | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm | 36 |
| University of Alabama at Birmingham Cancer Center | Acute Myeloid Leukemia, Malignant Solid Neoplasm, Recurrent Endometrial Carcinoma | 33 |
| University of Alabama | Chronic Kidney Disease(CKD), Type 2 DM, Type 2 Diabetes Mellitus (T2DM) | 31 |
| University of Alabama Birmingham | Amyotrophic Lateral Sclerosis, AML (Acute Myelogenous Leukemia), Acetabulum Fractures | 29 |
| The University of Alabama at Birmingham | Idiopathic Pulmonary Fibrosis, ALK-positive Histiocytosis, Advanced or Metastatic Solid Tumors | 28 |
| UAB | Opioid Overdose, Opioid Use Disorder, Alzheimer Disease | 15 |
| Children's of Alabama | Acute Kidney Injury, Acute Kidney Injury Due to Sepsis, Bowel Incontinence | 15 |
| University of Alabama Hospital | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 13 |
| Birmingham VA Medical Center, Birmingham, AL | Adult Growth Hormone Deficiency, Aging, Carcinoma, Hepatocellular | 11 |
| University of Alabama - Birmingham | Obstetrical Complications, CPPD - Calcium Pyrophosphate Deposition Disease, Cesarean Delivery | 7 |
| Alabama Oncology | Non-Small Cell Lung Cancer, Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer | 6 |
| University of Alabama At Birmingham Hospital | Advanced Solid Tumor, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma | 6 |
| University of Alabama, Birmingham | Acute Porphyrias, Alzheimer's Disease (AD), Bone Marrow Transplant (BMT) | 6 |
| Central Alabama Research | Colorectal Cancer, Early Breast Cancer, Influenza | 5 |
| Central Research Associates | Chronic Pain, Osteoarthritis, Knee, Chronic Low-back Pain | 5 |
| University of Alabama in Birmingham | Alzheimers Disease, Alzheimers Disease, Familial, Dementia | 5 |
| AllerVie Clinical Research | Atopic, Atopic Dermatitis, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) | 5 |
| Clinical Trial Site | Acute Hepatic Porphyria, Generalized Myasthenia Gravis, High Cardiovascular Risk | 4 |
| Alabama Clinical Therapeutics | Degenerative Disc Disease, Degenerative Disc Disease (DDD), Growth | 4 |
| Birmingham Clinical Research | Obesity, Overweight, Atherosclerotic Cardiovascular Disease (ASCVD) | 4 |
| O'Neal Comprehensive Cancer Center at UAB | Advanced Lung Carcinoma, Carcinoma, Endometrial Cancer | 4 |
| The Children's Hospital Alabama, University of Alabama at Birmingham | Cystic Fibrosis, Cystic Fibrosis (CF), Cystic Fibrosis Pulmonary Exacerbation | 4 |
| The Kirklin Clinic | Breast Cancer, Breast Neoplasm, Cancer | 4 |
| The Kirklin Clinic of UAB Hospital | Advanced or Metastatic Solid Tumors, Brain Neoplasms, Cachexia | 4 |
Active & Upcoming Studies in Birmingham (2026)
Recruiting trials in Birmingham grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (229 active studies)
- Developing Pilot Postoperative Guidelines for Improved Functional Outcomes After High-Risk Cancer Surgery · University of Alabama at Birmingham
- Monitoring Breast Cancer Immunotherapy Treatment With Advanced Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI) · EARLY_Phase 1 · University of Alabama at Birmingham
Cardiovascular (63 active studies)
- Monitoring Blood Pressure at Home and Pharmacy Telehealth · University of Alabama at Birmingham
- Feasibility and Acceptability of Three Component Intervention for the Heart Failure Care for Rural Dwelling Participants · University of Alabama at Birmingham
Diabetes & metabolic (62 active studies)
- MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients · University of Alabama at Birmingham
- Semaglutide for Low Back Pain · Phase 2 · Washington University School of Medicine
Neurology & pain (57 active studies)
- Semaglutide for Low Back Pain · Phase 2 · Washington University School of Medicine
- Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis · University of Alabama at Birmingham
Pediatric (23 active studies)
- Application to Predict Neonatal Apnea With Bradycardia · University of Alabama at Birmingham
- Video Inspired Discussions About Ethical Outcomes in Pediatrics · Massachusetts General Hospital
HIV / STI (21 active studies)
- A Study to Evaluate the Safety and Antiviral Activity of Two Human Monoclonal Antibodies (VRC07-523LS and PGT121.414.LS) During Analytic Treatment Interruption in Participants Living With HIV Who Initiated ART During Acute/Early HIV-1 Infection · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
- A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
Mental health & behavior (21 active studies)
- Mobile Thinking Intervention: A Inital Test · University of Alabama at Birmingham
- A Cognitive Mobile Intervention for Motivation in Psychotic Disorders · Phase 1, Phase 2 · University of Alabama at Birmingham
Vaccines (12 active studies)
- How Healthy Adults Respond to the Nasal Flu Vaccine · Phase 4 · University of Alabama at Birmingham
- Induction of Cross-protective Antibodies for Serogroup 33 by Pneumococcal Conjugate Vaccines · Phase 4 · University of Alabama at Birmingham
Eye & vision (5 active studies)
- Integrative Liver-Targeted Therapy for Diabetic Macular Edema: Using "Tauroursodeoxycholate" or Traditional Chinese Medicine. · Phase 2 · University of Alabama at Birmingham
- Intranasal Delivery of Octreotide for Treatment of Diabetic Macular Edema · Phase 1 · University of Alabama at Birmingham
Common conditions studied in Birmingham
- Obesity (21 active studies)
- Breast Cancer (15 active studies)
- Hypertension (13 active studies)
- Cancer (12 active studies)
- Ovarian Cancer (12 active studies)
- Overweight (12 active studies)
Leading research sponsors in Birmingham
- University of Alabama at Birmingham
- National Cancer Institute (NCI)
- Children's Oncology Group
- AstraZeneca
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Birmingham?
There are approximately 998 recruiting clinical trials in Birmingham, Alabama listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Birmingham pay participants?
Most recruiting trials in Birmingham compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Birmingham?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Birmingham?
The most common conditions under active study in Birmingham include Obesity (21), Breast Cancer (15), Hypertension (13), Cancer (12), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Birmingham?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Birmingham on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Birmingham?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Birmingham?
Recruiting research sites in Birmingham include University of Alabama at Birmingham, Children's Hospital of Alabama, University of Alabama at Birmingham Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Birmingham right now?
The largest active categories in Birmingham are Cancer & tumors (229), Cardiovascular (63), Diabetes & metabolic (62). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.